Keros Therapeutics, Inc. (KROS)
NASDAQ·Healthcare·Biotechnology
$10.35
+2.99%
Mkt Cap $327.66M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (7 analysts)
$102.60
Range $96.00 – $107.00
Implied Upside
+891.3%
Consensus $102.60 vs current $10.35
NASDAQ·Healthcare·Biotechnology
$10.35
+2.99%
Mkt Cap $327.66M
Buy
1
Hold
0
Sell
0
Price Target (7 analysts)
$102.60
Range $96.00 – $107.00
+891.3%
Consensus $102.60 vs current $10.35